FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · CNN — After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug...
New images of RSV may expose stubborn virus's weak points
May 21, 2024 — On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns...
There’s a new shot to protect newborns from a serious respiratory virus …
Oct 5, 2023 · A highly anticipated new shot that can protect newborns from the ravages of respiratory syncytial virus may not be available to some families this season because of uncertainties about...
Progress at last against RSV | Nature Medicine
Sep 14, 2023 · A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in northern climes, has strained...
FDA approves RSV vaccine for adults ages 60 and up - NBC News
May 3, 2023 · By Aria Bendix. The Food and Drug Administration on Wednesday approved the world's first RSV vaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades...
US approves 1st vaccine for RSV after decades of attempts | AP News
May 3, 2023 · The U.S. has approved the first vaccine for RSV, shots to protect older adults. The respiratory virus filled hospitals with wheezing babies last fall but also endangers seniors.
FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older - The …
May 31, 2023 · The Food and Drug Administration on Wednesday approved Pfizer’s vaccine against the respiratory syncytial virus, or R.S.V., for adults age 60 and older, the second approval granted for shots...
FDA approves first vaccine for RSV after decades of attempts
May 3, 2023 · WASHINGTON — The U.S. approved the first vaccine for RSV on Wednesday, allowing the sale of shots to protect older adults from a respiratory virus that’s most notorious for attacking babies but...
FDA Approves New Drug to Prevent RSV in Babies and Toddlers
Beyfortus is a monoclonal antibody that reduces the risk of RSV lower respiratory tract infection in neonates, infants and children up to 24 months of age. It is administered as a single ...
‘A good day’: FDA approves world’s first RSV vaccine - Nature
May 3, 2023 · The US Food and Drug Administration (FDA) has approved GSK’s vaccine against respiratory syncytial virus (RSV) for use in people aged 60 years and older. This is the first RSV vaccine to gain...